section name header

Info



A. Overview navigator

  1. Toxins produced by various strains of bacteria
    1. Staphylococcus aureus
    2. Streptococcus pyogenes
    3. Ehrlichia chaffeensis
  2. These toxins stimulate T lymphocytes leading to activation
  3. Activated T lymphocytes produce cytokines in large quantities
  4. Production of large quantities of cytokines leads to symptoms
    1. Skin rash
    2. Endothelial dysfunction - including nitric oxide production
    3. Hypotension
    4. Capilary leak
    5. Sepsis Syndrome may ensue

B. Clinical Diseases navigator

  1. Staphylococcal [9]
    1. Women <30 years using tampons at highest risk [3,5]
    2. Original descriptions in children with staphylococcal infections [4]
    3. Majority of cases of TSS had vaginal cultures positive for staphylococcus
    4. May occur with staphylococcal infections at other sites, often occult
    5. Causative staphylococcal strains produce toxin TSST-1
    6. TSST-1 is a "superantigen" encoded by a bacteriophage group 1
    7. TSST-1 binds to T cell receptor ß2 chains and causes massive T cell stimulation
  2. Streptococcus [1,6,7]
    1. Group A streptococcus is a major cause of rheumatic fever, pharyngitis, tonsillitis
    2. Well documented cause of Toxic Shock Syndrome
    3. Similar syndromes found in some patients with Group C or G Streptococci [8]
    4. Group A TSS is caused by non-rheumatogenic strains of S. pyogenes
    5. These strains are also linked to post-streptococcal glomerulonephritis
    6. Necrotizing fasciitis, with or without myonecrosis, is present in ~50% of cases
    7. Group A ß-hemolytic S. pyogenes associated with scarlet fever also described [6]
    8. The toxin responsible for Groups C or G toxic-shock like syndromes are not known [8]
    9. Increased risk in American Indians
  3. Ehrlichia [2]
    1. Ehrlichiosis can be associated with a toxic-shock-like syndrome
    2. Usually a benign rickettsial illness with rash and vomiting

C. Staphylococcal TSS navigator

  1. Fever - often >102°F
  2. Nausea, Vomiting, Myalgias
  3. Rash
    1. Often with mucous membrane involvement
    2. Desquamation of hands and feet may occur
  4. Headache, Confusion
  5. WBC > 15K/µL in ~50% of patients
  6. Hypotension - quite refractory in many cases
  7. Hepatitis, Renal Insufficiency, Thrombocytopenia
  8. Respiratory Distress Syndrome (rare)

D. Streptococcal TSS [1,6,7]navigator

  1. Isolation of Streptococcus pyogenes (Group A Streptococcus)
    1. Throat, Sputum, Vagina are most common primary sites
    2. Blood, CSF, Pleural, Peritoneal Fluid cultures must be obtained
    3. Blood cultures are often positive
    4. Groups C and G Streptococcal toxic shock-like syndromes have been described [8]
  2. Erythematous rash
    1. Macular
    2. Maculo-papular
  3. Presence of necrotizing fasciitis in about 50% of cases
  4. High fever, increased WBC as above

E. Treatmentnavigator

  1. Intensive supportive care is critical
  2. Antistaphylococcal Antibiotics
    1. Nafcillin or oxacillin preferred
    2. Cefazolin may be substituted in penicillin allergic patients
    3. Added gentamicin or rifampin for 2-3 days may improve bacterial clearance
  3. Streptococcal TSS
    1. In animal models, clindamycin appears to be more effective than penicillin
    2. Use of combination clindamycin + penicillin is suggested [7]
    3. No toxin-specific assays are currently available for general use
  4. Drainage of any abscess; removal of infected mechanical devices
  5. Role of glucocorticoids is unclear
  6. Intravenous Immune Globulin (IVIg) may be helpful in staphylococcal infections [9]


References navigator

  1. Working Group on Severe Streptococcal Infections. 1993. JAMA. 269(3):390 abstract
  2. Fichtenbaum CJ, Peterson LR, Weil GJ. 1993. Am J Med. 95(4):351 abstract
  3. Davis JP, Chesney PJ, Wand PJ, et al. 1980. NEJM. 303(25):1429 abstract
  4. Todd J, Fishaut M, Kapral F, Welch T. 1978. Lancet. 2:1116 abstract
  5. Shands KN, Schmid GP, Dan BB, et al. 1980. NEJM. 303(25):1436 abstract
  6. Stevens DL, Tanner MH, Winship J, et al. 1989. NEJM. 321(1):1 abstract
  7. Bisno AL and Stevens DL. 1996. NEJM. 334(4):240 abstract
  8. Hirose Y, Yagi K, Honda H, et al. 1997. Arch Intern Med. 337(16):1891
  9. Lowy FD. 1998. NEJM. 339(8):520 abstract